NCT03108885View on ClinicalTrials.gov

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

TerminatedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

May 25, 2020

Study Completion Date

May 25, 2020

Conditions
Esophageal NeoplasmEsophageal Neoplasms Malignancy UnspecifiedEsophageal Neoplasms MalignantCancer of EsophagusCancer of the EsophagusEsophageal CancerEsophagus CancerNeoplasm, Esophageal
Interventions
OTHER

Blood and Tissue Collection

Blood DNA will be isolated from plasma. Tumor DNA will be purified with a kit and amplified regions of 10 genes discovered to by mutated in whole exome sequencing.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03108885 - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence | Biotech Hunter | Biotech Hunter